key: cord-0951224-ph444fi5
authors: Ekşioğlu‐Demiralp, Emel; Alan, Servet; Sili, Uluhan; Bakan, Dilek; Ocak, İlhan; Yürekli, Rayfe; Alpay, Nadir; Görçin, Serpil; Yıldız, Alaattin
title: Peripheral innate and adaptive immune cells during COVID‐19: Functional neutrophils, pro‐inflammatory monocytes, and half‐dead lymphocytes
date: 2021-11-30
journal: Cytometry B Clin Cytom
DOI: 10.1002/cyto.b.22042
sha: 792a5e28c39fcb992e547cd0e493cbe4c72ea77c
doc_id: 951224
cord_uid: ph444fi5

BACKGROUND: A better understanding of innate and adaptive cells in COVID‐19 is necessary for the development of effective treatment methods and vaccines. METHODS: We studied phenotypic features of innate and adaptive immune cells, oxidative burst, phagocytosis, and apoptosis. One hundred and three patients with COVID‐19 were grouped according to their clinical features into the categories of mild (35%), moderate (40.8%), and severe (24.3%). RESULTS: Monocytes were CD16(+) pro‐inflammatory monocytes and tended to shed their HLA‐DR, especially in severe cases (p < 0.01). Neutrophils were mature and functional, although a decline of their CD10 and CD16 was observed (p < 0.01). No defect was found in the reactive oxygen species production and their apoptosis. The percentage of natural killer cells was in the normal range, whereas the percentages of CD8(+)NK and CD56(+)T lymphocytes were found to be high (p < 0.01). Although the absolute numbers of all lymphocyte subsets were low and showed a tendency for a gradual decrease in accordance with the disease progression, the most decreased absolute number was that of B lymphocytes, followed by CD4(+) T cells in the severe cases. The percentages of double‐negative T cells; HLA‐DR(+)CD3(+) and CD28(−)CD8(+) subsets were found to be significantly increased. Importantly, we demonstrated the increased baseline activation of caspase‐3 and increased lymphocyte apoptosis. CONCLUSION: We suggest that SARS‐CoV‐2 primarily affects the lymphocytes and not the innate cells. The increased baseline activation of Caspase‐3 could make the COVID‐19 lymphocytes more vulnerable to cell death. Therefore, this may interrupt the crosstalk between the adaptive and innate immune systems.

that the virus predominantly attacks the lungs causing pneumonia; other organ involvement is also possible, especially since the ACE-2 receptor is commonly found in the human body (Palasca et al., 2018) .

Indeed, past clinical experiences, since the inception of the pandemic, have shown that COVID-19 affects other organs and tissues as well (Xydakis et al., 2020) . SARS-CoV-2 belonging to the Coronavirus family has similarities with the Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) viruses in the context of ACE-2 receptor binding. However, it has been shown that SARS-Cov-2 has a higher virulence and stronger attachment to the ACE-2 receptor .

COVID-19 disease progression can be mild (81%), moderate (14%), and severe (5%) according to its pulmonary involvement and multiple organ failure (Wu & McGoogan, 2020) . The current data shows that the recent mortality rate of COVID-19 has increased up to 6.3%;

although it varies with age, gender, occupational group, and presence of comorbidities such as diabetes and hypertension (Coronavirus disease 2019, 2020; Li, Guan, et al., 2020; Targher et al., 2020) .

First-line of defense against intracellular invaders starts with innate immune cells, including monocytes, macrophages, and neutrophils. Activation of monocytes, macrophages, bystanders, and bridging dendritic cells by pattern recognition receptors, results in the release of the pro-inflammatory cytokines such as IL-1, IL-18, IL-33, and IL-6.

These cytokines activate the natural killer (NK) cells. NK activation is critical for viral defense due to their cellular cytotoxic function and their cytokine release in the particular interferon-gamma that activates both B and T cells (Paul, 2013) . Adaptive activation is a requirement for eliminating the invaders, constructing a proper immune memory, and also for limiting innate activation. Studies with T celldeficient or RAG-1 deficient mice demonstrated that the lack of lymphocytes resulted in a cytokine storm syndrome and death (Kim et al., 2007) . The crosstalk between the innate and adaptive immune systems constitutes our entire immune system, but every fine-tuned interaction could be a new target point for the various strategies of the virus to escape an immune attack.

The vicious circle of cytokine storm syndrome and hyperinflammation seen in COVID-19, causes the rapid deterioration of the patients' condition, as well as the increase in the mortality rate due to respiratory failure (Mehta et al., 2020; Ulhaq & Soraya, 2020) . Studies have shown that SARS-COV2 uses strategies to inhibit the interferon signaling pathway. Thus, it can be interpreted that it suppresses adaptive activation (Park & Iwasaki, 2020) .

Although the knowledge of immune pathogenesis of the disease is very limited, lymphopenia, the change of neutrophil/lymphocyte ratio in favor of neutrophils, as well as the increased level of LDH, CRP, and ferritin seems to vary in proportion with the severity of the disease. These parameters are used in the follow-up of the disease (Wang, Hou, et al., 2020; Yan et al., 2020) . In the autopsies of individuals who died due to COVID-19, neutrophils, monocyte/ macrophage infiltration, as well as a few helper T cells were detected in their lungs (Li, Jiang, et al., 2020; Yao et al., 2020) . It is noteworthy that NK and CD8+ cytotoxic T cells, which are the primary fighters against viral infection, were not present in the lungs.

Considering lymphopenia, it brings the suspicion that the SARS-CoV-2 virus may attach to other surfaces and cytoplasmic molecules other than ACE-2, and may also target the lymphoid system apoptosis similar to the SARS-CoV virus 7a protein, which induces apoptosis by competing to bind anti-apoptotic member of the Bcl-2 family, Bcl-XL (Tan et al., 2007) .

Immune profiles of patients with COVID-19 should be examined to get more information in order to establish more valid immune hypotheses on this disease (Tan et al., 2007) . Indeed, several immune impairments such as a low number of CD4 + , CD8 + T lymphocytes, NK cells as well as B lymphocytes have already been shown (Giamarellos-Bourboulis et al., 2020; Qin et al., 2020; Saksena & Chattopadhyay, 2021) . The functions of T lymphocytes measured by interferon-γ release following stimulation have been found to be in the normal range (Qin et al., 2020) . In this cross-sectional study, we aimed to investigate the peripheral innate and adaptive cells, burst and phagocytosis functions of monocyte and neutrophils, and lymphocyte apoptosis of patients with COVID-19 in various disease courses.

Delineation of the phenotypic and functional impairments created by the SARS-CoV-2 virus in the cells of innate and adaptive immune systems will help to better recognize the virus and to develop effective treatment and prevention strategies. findings were classified together as the "mild group" (n = 36; 35%); patients with more common CT involvement, but with oxygen saturation above 90% were classified as the "moderate group" (n = 42; 40.8%); patients with diffuse lung involvement along with oxygen saturation below 90% were grouped as the "severe group" (n = 25; 24.3%; Table 2 ). The mean hospitalization time for the latter two groups was 8 ± 8.5 days (range: 1-51). The study was approved by the Marmara University, Ethics Committee (no:08.05.2020/ 09.2020.541). Informed consent was obtained from the participants before the study.

One-hundred historical control subjects matched by age (47.8 ± 11

[29-74]) and gender (53 females, 47 males) were included in the study ( Populations were evaluated as a percentage and mean fluorescence intensity (MFI), which is a relative indicator of the number of molecules per unit cell.

The absolute numbers of subsets were calculated with a simple excel formula using lymphocyte numbers and ratios obtained from simultaneously tested hemograms of patients and controls. 

WBCs from 13 patients with a moderate clinical course and five healthy controls were isolated from heparinized blood samples by using ELS. Briefly, the cells (1 Â 10 5 /ml) were resuspended in PBS 

The statistical software package SPSS version 25.0 was used for all the statistical analyses. Statistical significance of differences between the groups was calculated by either ANOVA and followed by Bonferonni test as post-hoc, or by the Kruskal Wallis test followed by the Mann-Whitney U test as post-hoc when needed.

The p-values given in the text are the p-values obtained from the post hoc tests. Pearson rank correlation test was used where needed. Results were given as mean ± SD (in 95% confidence interval of mean). The significance of pre-post measurements was calculated using the Wilcoxon signed ranks test. Values of p < 0.05 were regarded as significant.

3.1 | The percentages and absolute numbers of leucocyte groups WBC counts, and percentages of lymphocytes, monocytes, and neutrophils, and their absolute numbers in patients with COVID-19 have been summarized in Table 3 . There was no difference found in total WBC numbers between the groups. The lymphocyte percentage was found to be significantly lower in the moderate (19.2% ± 10.8) and severe (15.1% ± 8.9) groups as compared to the mild group (30% ± 11.8; p < 0.01). Absolute lymphocyte count was lower in the moderate (1060 ± 929 cells/μl) and severe group (876 ± 676 cells/μl) compared to the mild group (1486 ± 827 cells/μl; p = 0.02). The percentage of monocytes was higher in the mild (10.9% ± 3.9) COVID-19 patients compared to moderate (8.1% ± 3.8) and severe (9.1% ± 4) patients (p < 0.05); whereas no difference was found the in absolute monocyte counts. In addition to the increase in the percentages of neutrophils, the absolute number of neutrophils was found to be statistically high in the moderate (70.8% ± 13; 4485 ± 2981 cells/μl) and

severe (74.5% ± 10.9; 4300 ± 2081 cells/μl) groups versus the mild group (57.3% ± 14; 2988 ± 1690 cells/μl; p < 0.01). It has been shown that lymphopenia deepened and granulocytosis increased, as both percentage and absolute number were proportional to the severity of the disease in accordance with the literature (Wang, Hou, et al., 2020) .

Phenotypic features of monocytes, neutrophils, NK and NK-like innate lymphoid cells (n = 93), and OB, phagocytosis, and apoptosis of monocyte and neutrophils in a group of patients (n = 13) were assessed.

As antigen-presenting cells, monocytes constitutively express HLA-DR. In our study group, the MFI of HLA-DR was 532 ± 138 in the mild; 456.7 ± 82 in the moderate; and 413 ± 100 in the severe group ( Figure 1a) . Although a gradual decrease in MFI values was observed between the groups, no statistical significance was found. However, HLA-DR MFI on monocytes from all the patient groups was Note: The percentage *(p < 0.01) and absolute numbers # (p = 0.02): of lymphocytes were significantly low in the moderate and severe groups compared to the mild group. The percentage of monocytes was high in the mild COVID-19 patients compared to moderate and severe patients *(p < 0.05). The percentage *(p < 0.01), and the absolute number # (p < 0.01) of neutrophils were significantly high in the moderate and severe groups in comparison to the mild group. Comparisons were analyzed by ANOVA followed by Bonferroni test as post hoc. The results were given as mean values in 95% CI ± SD. Abbreviation: NS, not significant.

significantly lower in comparison to the healthy controls (752 ± 352;

p < 0.01; Figure 1a ).

Expression of CD16 defines a subgroup known as proinflammatory monocytes (Chimen et al., 2017 

The OB of neutrophils and monocytes is measured as a percentage 

No difference has been found in the early and late apoptosis of monocytes and neutrophils between the patients with COVID-19 and the controls (n = 13).

As the bridging cells between innate and adaptive immune systems, the percentage and absolute numbers of NK cells (CD3 À CD16 + CD56 + )

were analyzed ( 

It was noticed that the CD3 À CD8 + cell subset increased in COVID-19 patients, and this subset was CD56 + as well (Figure 3b ). Therefore, it was considered that killer NK cells may increase in COVID-19. CD8 expression was then calculated on CD56 + CD3-gated cells in all patient groups and controls to identify the CD8+ NK cell subset. This was 29.6% ±19 in the control group, 44% ± 17 in the mild; 37% ± 15 in the moderate, and 39% ± 23 in the severe group (p < 0.001 in comparison to control; Figure 3c ). There was no difference between the groups. Thus, we demonstrated the increased 

A representative figure for flow cytometric evaluation of lymphocyte subsets is shown in Figure 3d -f. All percentages and the absolute numbers of lymphocyte subsets are given in Table 4 .

Initially, the percentage of B lymphocytes was tested together with both CD19 and CD20 markers in 1/3 of the patients. No difference was observed, and the study was continued only with CD19. The percentage of B lymphocytes (CD19+) was lower in all the COVID-19 patients compared to controls (6% ± 5 in the mild, 6.7% ± 6.6 in the moderate, 7% + ±6 in the severe group, and 10.8% ± 3.6 in the control group; p = 0.001, Figure 3d , group, a significant increase has been found in the expression of CD69 on CD4 + in comparison to the mild group (9.4% ±6.8 and 3.7% ±4.9 respectively; p < 0.01; Figure 4a ,b). The percentage of CD8 + CD69 + T cells was significantly increased in the severe group (45% ±34.5) in comparison to the mild group (13.3% ±12.4; *: p = 0.01; Figure 4c ,d).

F I G U R E 4 Expression of CD69 on CD4 + and CD8 + T cells and, increased CD56 + T cells in COVID-19 (a and c) representative CD69 versus CD4 and CD8 graphs gated on CD3 plots demonstrating increased CD69 expression on T lymphocytes from a patient with a severe course of COVID-19. The percentage of CD69 was calculated as the percentage within CD3 + CD4 + and CD3 + CD8 + gated cells (n = 67). (b) The percentage of CD69 on CD4 + T cells was significantly high in the severe patients (n = 13; 9.4% ±6.8) in comparison to the mild (n = 28; 3.7% ±4.9) and moderate patients (n = 26; 3.6% ±4; *: p < 0.01). (d) The percentage of CD8 + CD69 + T cells was significantly increased in the severe group (n = 17; 45% ±34.5) compared to the mild group (n = 30; 13.3% ±12.4; *: p = 0.01). (e) Representative CD3 versus CD56 plots demonstrating increased CD56 + T cells from a patient with COVID-19 versus a control. (f) The percentage of CD3 + CD56 + T cells was significantly high in patients with COVID-19. This was 6.7% ±4.3 in COVID-19 cases (n = 47) whereas it was 1.9% ±2 in control cases (n = 45). *: p < 0.01 [Color figure can be viewed at wileyonlinelibrary.com] 3.4.6 | An increase in CD56 + T cells (CD3 + CD56 + ) in patients with COVID-19 CD3 + CD56 + T cells represent a group of T cells that are cytotoxic to tumors and pathogens (Gianchecchi et al., 2018; Meraviglia et al., 2011) . The percentage of CD3 + CD56 + population was found to be high in COVID-19 patients as compared to controls (6.7% ±4.3 and 1.9% ±2, respectively; p < 0.01, Figure 4e ,f).

It has been suggested that CD3 + CD4 À CD8 À double-negative T cells are suppressive T cells (Voelkl et al., 2011) . We have found a significant increase in the percentage of CD3 + CD4 À CD8 À cell subset in both the moderate and severe groups (p < 0.01; Figure (p < 0.01; Figure 5d -f). CD8 + CD28 À T cells are known as a subset of regulatory T cells . The percentage of CD8 + CD28 À T cells were found to be significantly increased in all the groups of COVID-19 patients (p < 0.03; Figure 5g -i).

3.4.8 | Lymphocyte apoptosis in the periphery depends on the increased baseline activation of caspase-3 in patients with COVID-19

Special attention was focused on lymphocyte apoptosis. Lymphocyte early apoptosis ratio was high in patients with COVID-19 (p = 0.02; Figure 6a ). The percentages of lymphocyte late apoptosis and cell death were not different between the groups (Figure 6b) . However, total cell death, calculated by summing late apoptotic cells and cell death was significantly high in Covid-19 patients (42% ± 14.5

vs. 22.6% ± 12.3; p < 0.05; Figure 6a ). The fold increase was calculated by dividing MFIs of PMA stimulated to the unstimulated samples for each case. COVID-19 patients showed significantly lower fold increase than controls (2.3 ± 1.8 in COVID-19, 6.7 ± 4.2 in controls;

p < 0.01; Figure 6b ). It was an intriguing question as to how they have significantly lower stimulation responses, while the percentage of early apoptosis was significantly higher. We compared initial activation levels in unstimulated samples from both the controls and patients with COVID-19. We found that the initial fluorochrome conversion for caspase-3 was significantly higher in patients that indicated increased baseline activation of caspase-3 in COVID-19 (17% ± 8 vs. 6.3% ± 4.6; p = 0.01; Figure 6c ).

In our study, we demonstrated that components of the innate immune system during COVID-19 are well preserved. It has previously been shown to have reduced OB activity in patients with severe infections such as HIV and tuberculosis (Dobmeyer et al., 1995; Fiorenza et al., 2003; Zimmerman & Ringer, 1992) . However, we found no defect in the ROS production and apoptosis in monocytes and neutrophils.

There was a significant decrease in the absolute numbers of all lymphocyte subsets, particularly in B cell and CD4 + T cells, but also in NK and CD8 + T cells, which are associated with disease severity. CD8 + NK cell subset and CD56 + T cells and CD3 + HLA-DR + and CD8 + CD28 À T cell subsets were increased in COVID-19 patients.

Moreover, increased lymphocyte apoptosis is demonstrated, which may be responsible for the development of lymphopenia (summarized in Figure 7 ).

The immune response is a complex process that includes first innate activation followed by adaptive activation, which in turn F I G U R E 6 Lymphocyte early, late apoptosis, and cell death. controls the innate system in order not to harm its own cells with sustained reactions. Therefore, a proper immune response against microorganisms depends on a fine-tuned balance between innate and adaptive immune systems (Kim et al., 2007; Paul, 2013) .

Constitutive expression of HLA-DR on monocytes, which presents peptides to T cells, is a requirement for the communication between innate and adaptive systems. The decline of the expression of HLA-DR on monocytes is generally accepted as a marker of immune paralysis (Monneret et al., 2006; Quadrini et al., 2021 (Mehta et al., 2020) . On the other hand, CD16 + monocytes are a well-defined group known as non-classical monocytes considered as pro-inflammatory monocytes (Chimen et al., 2017) . We demonstrated that more than 50% of monocytes were (Shipp et al., 1991) . CD10 + neutrophils inhibit interferon-γ release and help the proliferation of T lymphocytes (Marini et al., 2017 patients. These subsets are known as potent cytotoxic and have a strong capacity to release IFN-γ (Spits et al., 2016) . We suggest that the decreased number of NK cells could be compensated by the increased number of cytotoxic cells.

We found that the absolute number of B lymphocytes was extremely reduced. A sufficient amount of immunoglobulin secretion from plasma cells in COVID-19 with that reduced number of B lymphocytes may seem not to be expected. It has already been shown that there was no peripheral B cell memory in SARS during the 6 years of follow-up (Tang et al., 2011; Yan et al., 2020) . It has previously been demonstrated that plasmablasts were increased in the peripheral blood during the viral infection (Wrammert et al., 2012) . However, we demonstrated that no plasmablast had been found in the periphery during the active infection. Hypothetically, the migration of B lymphocytes to the inflammation site might explain this excessive decrease of B lymphocytes. However, histopathological studies did not support this hypothesis, as they demonstrated the lack of lymphocytes in the lymph nodes and the spleen . Another possibility is that B lymphocytes may be one of the targets that are directly destroyed by SARS-CoV-2. The significant increase in the percentages of CD3 + and CD8 + T lymphocytes with their normal absolute numbers in the mild patients can be considered as a sign of a strong immune response at the beginning. In the mild group, while the absolute number of CD4 + T cells is still within normal limits, a decrease in both NK and B cell populations suggests that a careful phenotypic follow-up can be used to predict disease progression. Furthermore, while the decrease in the absolute numbers of NK and B cells remained the same throughout the disease progression in all the patient groups, a sharper decrease in CD4 and CD8 T lymphocytes in the moderate and severe groups is noteworthy. The sharp decrease in the number of CD4 + T cells in the severe group almost approaches the decrease in B lymphocytes.

HLA-DR expression on T lymphocytes has long been known to down-regulate the activated T cells. CD8 + CD28 À T cells represent another group of regulatory T cells that inhibit CD4 + T cell proliferation . On the other hand, HLA-DR on T cells has been used for a long time as one of the archetype markers on lymphocytes (along with CD38) to highlight T-cell activation (Cotner et al., 1983) .

We found increased CD3 + HLA-DR + , CD8 + CD28 À , and CD3 + CD4 À CD8 À T cell populations, especially in the moderate and severe groups. However, we could not demonstrate whether they have suppressive functions. These increases can be considered as an increase in regulatory T cell populations that down-regulate the adaptive system in COVID-19. However, functional assays are required for this issue. Another possibility is that the shift in these populations might be a result of the "over-activation" of the immune system, which in the end could also lead to a form of immune paralysis.

Our finding concerning increased early apoptotic activation indicates that the virus leads to a process that initiates the caspase 3 activation in lymphocytes. Indeed, a recent study demonstrated that the ORF-3a protein of SARS-Cov-2 induced apoptosis .

We found that Caspase-3 that was already active at the basal level, accelerates lymphocyte apoptosis in COVID-19. This data can be interpreted as an indication that SARS-Cov-2 is destructive for peripheral lymphocytes. One of the causes of lymphopenia in COVID-19 patients might be the elevated basal caspase-3 activation in lymphocytes for an unknown reason.

In our study, we found significant differences in peripheral lymphocyte subgroups between COVID patients and healthy controls.

We also described some associations of disease severity and peripheral subset analysis. However, when evaluating these findings, it should be kept in mind that historical control was used as the control group. Antibodies used for historical controls were purchased from the same company to use in the study samples. Both the historical control and patients' samples were tested with the same FACS instrument (FACSCalibur, Becton Dickinson Inc). Also, the same type of tube (EDTA tubes) was used in both the historical controls and our samples. For these reasons, we thought that the risk of variability and bias was minimized, and that historical control could be used with confidence. This is the main limitation of the study.

This study, in which we examine partially phenotypic and functional characteristics of innate and adaptive immune system cells,

shows that the innate immune system functions are complete and competent; but the adaptive immune system is not adequate, which has a low number of half-dead lymphocytes, to combat the viral infection in COVID-19. We suggest that Sars-Cov2 primarily targets lymphocytes, which then might impair the communication between innate-adaptive immune systems. In this context, it will be very impor-

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. medRxiv

Monocyte subsets coregulate inflammatory responses by integrated signaling through TNF and IL-6 at the endothelial cell Interface

Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content

Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts

Impaired neutrophil function in patients with pulmonary tuberculosis and its normalization in those undergoing specific treatment, except the HIV-coinfected cases

Complex immune dysregulation in COVID-19 patients with severe respiratory failure

NK cells in autoimmune diseases: Linking innate and adaptive immune responses

COVID-19) situation report -130

Adaptive immune cells temper initial innate responses

Clinical and pathological investigation of severe COVID-19 patients

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: A systematic review and meta-analysis

Human CD8

Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding

Mature CD10. Blood

COVID-19: Consider cytokine storm syndromes and immunosuppression

γδ T cells cross-link innate and adaptive immunity in mycobacterium tuberculosis infection

Viruses with singlestranded, positive-sense RNA genomes

Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock

TIS-SUES 2.0: An integrative web resource on mammalian tissue expression

Type I and type III Interferons -induction, signaling, evasion, and application to combat COVID-19

Fundamental immunology (Vol. xviii

Dysregulation of immune response in patients with COVID-19 in Wuhan China

A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials

The ORF3a protein of SARS

CoV-2 induces apoptosis in cells

Illuminating the immunopathology of SARS-CoV-2

Structural basis of receptor recognition by SARS-CoV-2

CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation

Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19

NK cells and type 1 innate lymphoid cells: Partners in host defense

Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein

Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: A six-year follow-up study

Patients with diabetes are at higher risk for severe illness from COVID-19

Interleukin-6 as a potential biomarker of COVID-19 progression

Characterization of the immunoregulatory function of human TCR-αβ+ CD4-CD8-double-negative T cells

The laboratory tests and host immunity of COVID-19 patients with different severity of illness

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

Rapid and massive virusspecific plasmablast responses during acute dengue virus infection in humans

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Smell and taste dysfunction in patients with COVID-19. The Lancet Infectious Diseases

Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study

A pathological report of three COVID-19 cases by minimal invasive autopsies

Inflammatory host responses in sepsis

Peripheral innate and adaptive immune cells during COVID-19: Functional neutrophils, pro-inflammatory monocytes, and half-dead lymphocytes